ES2058259T3 - Antigenos sinteticos para la deteccion de enfermedad relacionada con sida causada por lav-2. - Google Patents

Antigenos sinteticos para la deteccion de enfermedad relacionada con sida causada por lav-2.

Info

Publication number
ES2058259T3
ES2058259T3 ES88302596T ES88302596T ES2058259T3 ES 2058259 T3 ES2058259 T3 ES 2058259T3 ES 88302596 T ES88302596 T ES 88302596T ES 88302596 T ES88302596 T ES 88302596T ES 2058259 T3 ES2058259 T3 ES 2058259T3
Authority
ES
Spain
Prior art keywords
lav
aids
detection
related disease
disease caused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88302596T
Other languages
English (en)
Other versions
ES2058259T5 (es
Inventor
Wesley L Cosand
Andrew J Watson
Raymond L Houghton
Luc Montagnier
Marc Alizon
Solange Chamaret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Genetic Systems Corp
Original Assignee
Institut Pasteur de Lille
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26706000&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2058259(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Institut Pasteur de Lille, Genetic Systems Corp filed Critical Institut Pasteur de Lille
Application granted granted Critical
Publication of ES2058259T3 publication Critical patent/ES2058259T3/es
Publication of ES2058259T5 publication Critical patent/ES2058259T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

SE DESCRIBEN SECUENCIAS DE PEPTIDOS CON PROTEINAS MIMICAS INMUNOLOGICAMENTE CODIFICADAS POR LAS REGIONES ENV Y GAG DE LAV-2, EN RETROVIRUS ASOCIADO CON EL SIDA. LOS PEPTIDOS PUEDEN SER USADOS EN VARIOS ENSAYOS DE UNION ESPECIFICOS PARA DETECTAR LA PRESENCIA DE ANTICUERPOS DE LAV-2 EN INDIVIDUOS PREVIAMENTE EXPUESTOS AL VIRUS. LOS PEPTIDOS PERMITEN DISTINGUIR ENTRE LA PRESENCIA DE ANTICUERPOS DE LAV-2 Y ANTICUERPOS DE HIV-1.
ES88302596T 1987-03-25 1988-03-24 Antigenos sinteticos para la deteccion de enfermedad relacionada con sida causada por lav-2. Expired - Lifetime ES2058259T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3040387A 1987-03-25 1987-03-25
US3540887A 1987-04-07 1987-04-07

Publications (2)

Publication Number Publication Date
ES2058259T3 true ES2058259T3 (es) 1994-11-01
ES2058259T5 ES2058259T5 (es) 2000-09-01

Family

ID=26706000

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88302596T Expired - Lifetime ES2058259T5 (es) 1987-03-25 1988-03-24 Antigenos sinteticos para la deteccion de enfermedad relacionada con sida causada por lav-2.

Country Status (6)

Country Link
EP (1) EP0284383B2 (es)
AT (1) ATE108457T1 (es)
CA (1) CA1341436C (es)
DE (1) DE3850593T3 (es)
ES (1) ES2058259T5 (es)
GR (1) GR3033885T3 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701628D0 (sv) * 1987-04-16 1987-04-16 Erling Norrby Medel for analys mm
US5780038A (en) * 1987-11-16 1998-07-14 Roche Diagnostic Systems, Inc. HIV-2 envelope polypeptides
DE3879881D1 (de) * 1987-11-16 1993-05-06 Hoffmann La Roche Rekombinante hiv-2 polypeptide.
EP0362927A3 (en) * 1988-10-06 1990-11-14 Akzo N.V. Synthetic polypeptides immunochemically reactive with hiv antibodies
GB8828098D0 (en) * 1988-12-01 1989-01-05 Wellcome Found Peptides
GB8828097D0 (en) * 1988-12-01 1989-01-05 Wellcome Found Peptides
GB8910145D0 (en) * 1989-05-03 1989-06-21 Connaught Lab Synthetic peptides for an hiv-1 vaccine
CA2017021A1 (en) * 1989-05-22 1990-11-22 Johannes Jacobus Schalken Diagnostic test for detecting antibodies directed against antigens of one or more related viruses
DE69129207T2 (de) * 1990-01-16 1998-10-08 Orgenics Ltd Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
FR2657016B1 (fr) * 1990-01-16 1995-08-25 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910002374B1 (ko) * 1985-04-29 1991-04-20 제네틱 시스템즈 코포레이션 Aids 관련질병의 검출을 위한 합성항원
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
FR2593190B1 (fr) * 1986-01-22 1989-10-20 Pasteur Institut Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida

Also Published As

Publication number Publication date
DE3850593T2 (de) 1994-12-15
DE3850593D1 (de) 1994-08-18
EP0284383B1 (en) 1994-07-13
ATE108457T1 (de) 1994-07-15
ES2058259T5 (es) 2000-09-01
EP0284383A1 (en) 1988-09-28
EP0284383B2 (en) 2000-04-05
GR3033885T3 (en) 2000-11-30
DE3850593T3 (de) 2001-01-04
CA1341436C (en) 2003-08-05

Similar Documents

Publication Publication Date Title
EA200100943A1 (ru) Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител
FI870447A (fi) Htlv-iii-hoeljepeptider.
DE69334148D1 (de) HIV-Peptide
DK268588A (da) Syntetisk peptidantigen til detektering af hiv-2-infektion
ES2091777T3 (es) Procedimiento para preparar un ensayo inmunologico de transferencia western.
NO881151L (no) Syntetisk hiv-1-antigen.
ES2115584T3 (es) Antigeno sintetico para la deteccion de enfermedades referentes al sida.
ES2058259T5 (es) Antigenos sinteticos para la deteccion de enfermedad relacionada con sida causada por lav-2.
ES2066887T3 (es) Anticuerpo monoclonal para diferenciar individuos seropositivos hiv-2 de los hiv-1.
ATE128738T1 (de) Verfahren zum schnellen und empfindlichen nachweis von igm-antikörpern gegen retrovirale antigene.
ATE128716T1 (de) Hiv-peptide und methoden für den nachweis von hiv.
EA200300335A1 (ru) Регуляторные и вспомогательные пептиды вич, антигены, вакцинные композиции, набор для иммуноанализа и способ обнаружения антител, индуцируемых вич
Gupta et al. Detection of human immunodeficiency virus by reverse transcriptase assay, antigen capture assay, and radioimmunoassay
ES2054769T3 (es) Polipeptidos hiv-2 recombinantes.
ES2085631T3 (es) Inmunoensayo para la deteccion simultanea de anticuerpos del hiv-1, hiv-2, htlv-i y htlv-ii.
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
ES2113860T3 (es) Peptidos con grupos tioles de cisteina protegidos, utiles en los ensayos inmunologicos.
Jiang et al. Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infection
Huisman et al. Detection of early anti-p24 HIV responses in EIA-and immunoblot-negative individuals
Bolton et al. Unique p24 epitope marker to identify multiple human immunodeficiency virus variants in blood from the same individuals
DE3854665D1 (de) Verfahren zum schnellen und empfindlichen nachweis von hiv-1-antikörpern.
ES2053014T3 (es) El retrovirus siv cpz-ant y sus usos.
Ubol et al. Anti-HIV positivity in Thailand: the usefulness of another ELISA test kit and Western blot as confirmatory tests
IT1226711B (it) Antigeni sintetici utili per la diagnosi della malaria da plasmodium vivax.
ES2129358B1 (es) Procedimiento de deteccion en una sola prueba de anticuerpos anti-virus de la hepatitis c, de la inmunodeficiencia humano y antigeno de superficie del virus de la hepatitis b".

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 284383

Country of ref document: ES